REGENERON PHARMACEUTICALS, INC. (REGN) Gross margin 2016–2020
REGENERON PHARMACEUTICALS, INC. (REGN) gross margin by fiscal year — reported gross profit divided by reported revenue.
95.3%FY2020 · since FY2016: 95.0% → 95.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | 95.3% | -1.1 pp |
| FY2019 | 96.4% | +0.3 pp |
| FY2018 | 96.1% | -0.6 pp |
| FY2017 | 96.7% | +1.7 pp |
| FY2016 | 95.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More REGN financial trends
REGN RevenueREGN Net incomeREGN Net marginREGN Gross profitREGN Operating incomeREGN Operating marginREGN Operating cash flowREGN Free cash flowREGN Capital expendituresREGN Return on equityREGN Stock buybacksREGN Dividends paidREGN Total assetsREGN Total liabilitiesREGN Shareholders’ equityREGN overview →